CINECA IRIS Institutional Research Information System

MANCINA, ROSELLINA MARGHERITA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.299
NA - Nord America 555
SA - Sud America 389
EU - Europa 276
Continente sconosciuto - Info sul continente non disponibili 123
AF - Africa 22
AN - Antartide 1
Totale 2.665
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 500
SG - Singapore 392
BR - Brasile 302
HK - Hong Kong 219
CN - Cina 200
VN - Vietnam 150
KR - Corea 139
BD - Bangladesh 122
IT - Italia 105
AR - Argentina 39
FR - Francia 39
GB - Regno Unito 27
ID - Indonesia 22
CA - Canada 21
DE - Germania 20
EC - Ecuador 16
MX - Messico 15
PL - Polonia 14
CO - Colombia 11
IN - India 11
ZA - Sudafrica 10
PY - Paraguay 9
LT - Lituania 8
UA - Ucraina 8
IQ - Iraq 7
NL - Olanda 7
RU - Federazione Russa 7
SE - Svezia 7
ES - Italia 6
JM - Giamaica 6
CH - Svizzera 5
EG - Egitto 5
JP - Giappone 5
PE - Perù 5
SA - Arabia Saudita 5
UZ - Uzbekistan 5
BE - Belgio 4
HN - Honduras 4
KG - Kirghizistan 4
TR - Turchia 4
EE - Estonia 3
PK - Pakistan 3
PT - Portogallo 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
CL - Cile 2
DK - Danimarca 2
DZ - Algeria 2
GH - Ghana 2
GR - Grecia 2
IE - Irlanda 2
KZ - Kazakistan 2
MA - Marocco 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
VE - Venezuela 2
AO - Angola 1
AQ - Antartide 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GT - Guatemala 1
HT - Haiti 1
IL - Israele 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NP - Nepal 1
PR - Porto Rico 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 2.544
Salva come PNG Salva come JPEG
Città #
Hong Kong 219
Singapore 153
Seoul 139
Ashburn 93
Chicago 70
Ho Chi Minh City 57
San Jose 52
Beijing 46
Hanoi 29
São Paulo 28
Los Angeles 19
Frankfurt am Main 15
New York 15
Hillsboro 14
Rio de Janeiro 13
Warsaw 13
Dallas 12
Santa Clara 11
Rome 10
Haiphong 9
Guayaquil 8
London 8
Milan 8
Dhaka 7
Montreal 7
Naples 7
Buffalo 6
Da Nang 6
Reston 6
Belo Horizonte 5
Belém 5
Gothenburg 5
Lima 5
Mexico City 5
Santo André 5
Tashkent 5
Thái Bình 5
Tokyo 5
Toronto 5
Zurich 5
Baghdad 4
Bishkek 4
Boston 4
Brasília 4
Brussels 4
Curitiba 4
Florence 4
Hải Dương 4
Johannesburg 4
Juiz de Fora 4
Palermo 4
Phoenix 4
Potenza 4
Quito 4
São José dos Campos 4
Araçatuba 3
Betim 3
Bexley 3
Biên Hòa 3
Bogotá 3
Cairo 3
Can Tho 3
Caxias do Sul 3
Cologna Veneta 3
Florianópolis 3
Kingston 3
Limburg an der Lahn 3
Manchester 3
Medellín 3
Montevideo 3
Ninh Bình 3
Orem 3
Ottawa 3
Quilmes 3
Ribeirão Preto 3
Riyadh 3
Rondonópolis 3
San Francisco 3
St Petersburg 3
São José 3
São José do Rio Preto 3
Tallinn 3
Uberlândia 3
Accra 2
Amsterdam 2
Ankara 2
Araguaína 2
Athens 2
Açailândia 2
Bari 2
Bento Gonçalves 2
Boardman 2
Bologna 2
Bratislava 2
Brooklyn 2
Buenos Aires 2
Camaçari 2
Canaã dos Carajás 2
Cape Town 2
Caruaru 2
Totale 1.313
Salva come PNG Salva come JPEG
Nome #
Beta-glucan, inositol and digestive enzymes improve quality of life of patients with inflammatory bowel disease and irritable bowel syndrome 81
Downregulation of the MARC1 p.A165 risk allele reduces hepatocyte lipid content by increasing beta-oxidation. 76
Genetic Susceptibility to Chronic Liver Disease in Individuals from Pakistan 56
PSD3 downregulation confers protection against fatty liver disease 54
Effects of listening to music in digestive endoscopy: A prospective intervention study led by nursing 51
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker 49
Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches 48
TM6SF2 and PNPLA3: a potential dynamic duo? 48
Exome-Wide Association Study on Alanine Aminotransferase Identifies Sequence Variants in the GPAM and APOE Associated With Fatty Liver Disease 47
The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent 47
Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease 47
Transmembrane 6 superfamily member 2 gene E167K variant impacts on steatosis and liver damage in chronic hepatitis C patients 46
Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia 44
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage 44
Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liver 44
Individuals with familial hypercholesterolemia and cardiovascular events have higher circulating Lp(a) levels 43
Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells 43
Cellular Genome-Scale Metabolic Modeling Identifies New Potential Drug Targets Against Hepatocellular Carcinoma 43
Ulcerative Colitis as an Independent Risk Factor for Hepatic Steatosis 43
Recombinant PNPLA3 protein shows triglyceride hydrolase activity and its I148M mutation results in loss of function 42
Cross talk between liver and adipose tissue: A new role for PNPLA3? 42
Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity 42
PNPLA3 I148M polymorphism and progressive liver disease 41
Development and Validation of a Score for Fibrotic Nonalcoholic Steatohepatitis 41
Accuracy of controlled attenuation parameter for assessing liver steatosis in individuals with morbid obesity before bariatric surgery 41
An Integrated Understanding of the Rapid Metabolic Benefits of a Carbohydrate-Restricted Diet on Hepatic Steatosis in Humans 40
Virtual genetic diagnosis for familial hypercholesterolemia powered by machine learning 39
LPIAT1/MBOAT7 depletion increases triglyceride synthesis fueled by high phosphatidylinositol turnover 39
ANGPTL3 Downregulation Increases Intracellular Lipids by Reducing Energy Utilization 39
Genetic variants in the MTHFR are not associated with fatty liver disease 39
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 38
PNPLA3 I148M Variant Influences Circulating Retinol in Adults with Nonalcoholic Fatty Liver Disease or Obesity 38
MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals 38
ANGPTL4 gene E40K variation protects against obesity‐associated dyslipidemia in participants with obesity 38
New Diagnostic and Prognostic Models for the Development of Alcoholic Cirrhosis Based on Genetic Predisposition and Alcohol History 37
Genome-wide interaction study with BMI identifies CYP7A1 and GIPR as genetic modulators of MASLD 37
Generation and validation of a classification model to diagnose familial hypercholesterolaemia in adults 37
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infection 35
Rare ATG7 genetic variants predispose patients to severe fatty liver disease 35
A two gene-based risk score predicts alcoholic cirrhosis development in males with at-risk alcohol consumption 34
The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids 34
Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in mice 33
The COBLL1 C allele is associated with lower serum insulin levels and lower insulin resistance in overweight and obese children 33
Macrophage scavenger receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease 33
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes 33
Genetic diagnosis of familial hypercholesterolaemia by targeted next‐generation sequencing 33
Mitochondrial amidoxime-reducing component 1 p.Ala165Thr increases protein degradation mediated by the proteasome 32
Gastrointestinal Symptoms of and Psychosocial Changes in Inflammatory Bowel Disease: A Nursing-Led Cross-Sectional Study of Patients in Clinical Remission 32
High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease 32
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals 32
Paradoxical dissociation between hepatic fat content and de novo lipogenesis due to PNPLA3 sequence variant 32
The IRS1 rs2943641 Variant and Risk of Future Cancer Among Morbidly Obese Individuals 31
PNPLA3 overexpression results in reduction of proteins predisposing to fibrosis 31
Effects of PNPLA3 I148M on hepatic lipid and very-low-density lipoprotein metabolism in humans 31
PCSK9 rs11591147 R46L Loss-of-Function Variant Protects Against Liver Damage in Individuals with NAFLD 31
Patatin-like phospholipase domain-containing 3 (PNPLA3) I148M (rs738409) affects hepatic VLDL secretion in humans and in vitro 31
Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease 30
MBOAT7 is anchored to endomembranes by six transmembrane domains 30
PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells 29
Effects of TM6SF2 E167K on hepatic lipid and very low-density lipoprotein metabolism in humans 29
Transmembrane-6 superfamily member 2 (TM6SF2) E167K variant increases susceptibility to hepatic steatosis in obese children 29
The rs2294918 E434K variant modulates PNPLA3 expression and liver damage 28
Statin use and non-alcoholic steatohepatitis in at risk individuals 28
IL32 downregulation lowers triglycerides and type I collagen in di-lineage human primary liver organoids 27
Natural Extracts as Modifiers of Intracellular Lipid Handling 27
Telomerase reverse transcriptase germline mutations and hepatocellular carcinoma in patients with nonalcoholic fatty liver disease 24
PCSK9 rs11591147 R46L loss-of-function variant protects against liver damage in individuals with non-alcoholic fatty liver 24
PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients 23
Validation of Interleukin-32 as a new circulating fatty liver biomarker 23
Identification and characterization of two novel mutations in the LPL gene causing type I hyperlipoproteinemia 23
MTARC1 p.A165 ablation reduces hepatocellular carcinoma aggressiveness in vitro and in vivo 6
Human genetics of steatotic liver disease: insights into insulin resistance and lipid metabolism 5
Totale 2.665
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.304
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.304
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202467 0 0 0 0 0 0 0 0 30 36 0 1
2024/2025720 19 55 2 9 98 147 76 25 66 38 154 31
2025/20261.790 118 115 299 367 160 26 62 132 152 101 163 95
2026/202788 61 27 0 0 0 0 0 0 0 0 0 0
Totale 2.665